Trial Site Detail

 

Drug:
IPI-504
Trial:
Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

St Augustinus Ziekenhuis

     
Wilrijk , Brussels 1200
Belgium

 

Principal Investigator:
Luc Dirix, MD
Contact:
Hide Haes +32 (0) 3 443 3759 hide.maes@gza.be
Activation Status of this Site:
Closed
Notes about this Site:
St Augustinus Ziekenhuis Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.